
Bolt Biotherapeutics, Inc.
BOLTHealthcare|Biotechnology|US
$6.54
+0.16 (+2.51%)
Tangible Book / Share
$7.48
Cash / Share
$10.41
Next Earnings Report
Mar 31, 2027
EPS est. -$3.85 · Revenue est. $450.0K
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (1)
May 2027
Est. completion
P1P2Gastric Cancer Adenocarcinoma Metastatic
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
NCT06921837n=122
Recent Press Releases
INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – RRC, SGRY, BOLT and PCRX - IS IT A FAIR DEAL FOR YOU?
Nov 4, 2026 · GlobeNewsWire
Bolt Biotherapeutics to Participate in Upcoming Conferences
Nov 3, 2026 · GlobeNewsWire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT)
Oct 26, 2026 · PRNewsWire
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
Oct 23, 2026 · GlobeNewsWire
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026 · GlobeNewsWire
SEC Filings (45)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 23, 2026 | 8-K | Material event | DocumentIndex |
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2026 | 8-K | Material event | DocumentIndex |
| Jun 11, 2026 | 8-K | Material event | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| Apr 28, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 28, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 12, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 12, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 12, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Oct 2, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2025 | 8-K | Material event | DocumentIndex |
| Jun 6, 2025 | 8-K | Material event | DocumentIndex |
| Jun 4, 2025 | 8-K | Material event | DocumentIndex |
| May 28, 2025 | 8-K | Material event | DocumentIndex |
| May 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2025 | 8-K | Material event | DocumentIndex |
| Apr 25, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 25, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 16, 2025 | 8-K | Material event | DocumentIndex |
| Apr 16, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 15, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 24, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Mar 24, 2025 | 10-K | Annual report | DocumentIndex |
| Mar 24, 2025 | 8-K | Material event | DocumentIndex |